{{Drugbox
| IUPAC_name = 1,1&prime;-propane-1,3-diylbis{4-[(''E'')-(hydroxyimino)methyl]pyridinium} dibromide
| image = Trimedoxime bromide structure.svg
| width = 250

<!--Clinical data-->
| tradename =  
| pregnancy_AU = <!-- A, B1, B2, B3, C, D, X -->
| pregnancy_US = <!-- A, B, C, D, X -->
| pregnancy_category =  
| legal_AU = <!-- S2, S3, S4, S5, S6, S7, S8, S9 or Unscheduled-->
| legal_CA = <!-- Schedule I, II, III, IV, V, VI, VII, VIII -->
| legal_UK = <!-- GSL, P, POM, CD, or Class A, B, C -->
| legal_US = <!-- OTC / Rx-only / Schedule I, II, III, IV, V -->
| legal_status = Experimental; in military use
| routes_of_administration = [[Intramuscular injection]]

<!--Pharmacokinetic data-->
| bioavailability =  
| protein_bound =  
| metabolism =  
| elimination_half-life = 2 hours (mean)
| excretion =  

<!--Identifiers-->
| CAS_number = 56-97-3
| ATC_prefix = None
| ATC_suffix =  
| PubChem = 5359236
| DrugBank =  
| ChemSpiderID = 4514238
| UNII_Ref = {{fdacite|correct|FDA}}
| UNII = ED0GXI9825

<!--Chemical data-->
| C=15 | H=18 | N=4 | O=2 | Br=2
| molecular_weight = 446.14 g/mol
}}

'''Trimedoxime bromide''' ([[International Nonproprietary Name|INN]]), also known as '''dipyroxime''' or '''TMB-4''', is an [[oxime]] used in the treatment of [[organophosphate poisoning]].

==References==
{{Reflist|2}}

{{Antidotes}}
{{Acetylcholine metabolism and transport modulators}}

[[Category:Antidotes]]
[[Category:Chemical substances for emergency medicine]]
[[Category:Oximes]]
[[Category:Pyridinium compounds]]


{{pharma-stub}}